Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)

Matchar DB, Kulasingam SL, Havrilesky L, Mann LO, Myers ER, McCrory DC, Patwardhan M, Prosnitz R
Record ID 32004000167
Authors' objectives:

This report aims to evaluate the performance of 18Fluro-deoxy-glucose positron emission tomography (FDG-PET) when compared to conventional imaging (such as computed tomography (CT) and magnetic resonance (MRI)) and when used as an adjunct to conventional imaging for patient management of six different cancers (brain, cervical, ovarian, pancreatic, small cell lung, and testicular).

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Tomography, Emission-Computed
  • Brain Neoplasms
  • Carcinoma, Small Cell
  • Lung Neoplasms
  • Ovarian Neoplasms
  • Pancreatic Neoplasms
  • Testicular Neoplasms
  • Uterine Cervical Neoplasms
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: martin.erlichman@ahrq.hhs.gov
Contact Email: martin.erlichman@ahrq.hhs.gov
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.